ACCELERON PHARMA INC's ticker is and the CUSIP is 00434H908. A total of 4 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $90,000 | +3.4% | 700 | 0.0% | 0.00% | – |
| Q2 2021 | $87,000 | +569.2% | 700 | +69900.0% | 0.00% | – |
| Q1 2021 | $13,000 | -48.0% | 1 | -50.0% | 0.00% | – |
| Q4 2020 | $25,000 | -95.8% | 2 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $596,000 | -81.4% | 53 | -84.3% | 0.00% | -80.0% |
| Q2 2020 | $3,210,000 | +16.7% | 337 | +10.1% | 0.01% | 0.0% |
| Q1 2020 | $2,750,000 | +201.9% | 306 | +77.9% | 0.01% | +150.0% |
| Q4 2019 | $911,000 | +12914.3% | 172 | +8500.0% | 0.00% | – |
| Q3 2019 | $7,000 | -75.0% | 2 | -71.4% | 0.00% | – |
| Q2 2019 | $28,000 | -68.2% | 7 | -63.2% | 0.00% | – |
| Q1 2019 | $88,000 | -91.3% | 19 | -91.8% | 0.00% | -100.0% |
| Q4 2018 | $1,010,000 | +98.4% | 232 | +160.7% | 0.00% | +50.0% |
| Q3 2018 | $509,000 | -77.6% | 89 | -81.0% | 0.00% | -77.8% |
| Q2 2018 | $2,270,000 | +18816.7% | 468 | +895.7% | 0.01% | +800.0% |
| Q1 2018 | $12,000 | -29.4% | 47 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | +142.9% | 47 | +370.0% | 0.00% | – |
| Q3 2017 | $7,000 | -53.3% | 10 | -76.2% | 0.00% | -100.0% |
| Q2 2017 | $15,000 | +400.0% | 42 | -38.2% | 0.00% | – |
| Q1 2017 | $3,000 | – | 68 | +106.1% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 33 | -85.7% | 0.00% | -100.0% |
| Q3 2016 | $74,000 | – | 231 | +7600.0% | 0.01% | – |
| Q2 2016 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 1 | -93.8% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | +150.0% | 16 | +77.8% | 0.00% | – |
| Q3 2015 | $4,000 | +100.0% | 9 | +80.0% | 0.00% | – |
| Q2 2015 | $2,000 | -33.3% | 5 | -66.7% | 0.00% | – |
| Q1 2015 | $3,000 | -80.0% | 15 | -83.9% | 0.00% | -100.0% |
| Q4 2014 | $15,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|